Bank of America’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-800
| Closed | -$5K | – | 6519 |
|
2017
Q2 | $5K | Sell |
800
-1,590
| -67% | -$9.94K | ﹤0.01% | 5841 |
|
2017
Q1 | $9K | Sell |
2,390
-7,000
| -75% | -$26.4K | ﹤0.01% | 5813 |
|
2016
Q4 | $35K | Sell |
9,390
-560
| -6% | -$2.09K | ﹤0.01% | 5313 |
|
2016
Q3 | $41K | Sell |
9,950
-2,190
| -18% | -$9.02K | ﹤0.01% | 5056 |
|
2016
Q2 | $56K | Sell |
12,140
-3,100
| -20% | -$14.3K | ﹤0.01% | 4996 |
|
2016
Q1 | $50K | Buy |
15,240
+390
| +3% | +$1.28K | ﹤0.01% | 4983 |
|
2015
Q4 | $51K | Sell |
14,850
-55,229
| -79% | -$190K | ﹤0.01% | 5062 |
|
2015
Q3 | $255K | Buy |
70,079
+14,228
| +25% | +$51.8K | ﹤0.01% | 4279 |
|
2015
Q2 | $278K | Buy |
55,851
+26,327
| +89% | +$131K | ﹤0.01% | 4145 |
|
2015
Q1 | $237K | Buy |
+29,524
| New | +$237K | ﹤0.01% | 3921 |
|